CEFTIOCYL
Country: Austria
Language: English
Source: HMA (Heads of Medicines Agencies)
Summary of Product characteristics
(SPC)
04-09-2013
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
ceftiofur hydrochloride 50 mg/ml
Available from:
Vetoquinol S.A.
ATC code:
QJ01D
Pharmaceutical form:
Suspension for injection
Therapeutic group:
LACTAM ANTIBACTERIALS
Therapeutic area:
Cattle, Pigs
Authorization date:
2010-02-06
Summary of Product characteristics
SUMMARY OF PRODUCT CHARACTERISTICS
1. NAME OF THE VETERINARY MEDICINAL PRODUCT
CEFTIOCYL 50 MG/ML, SUSPENSION FOR INJECTION FOR CATTLE AND PIGS
2. QUALITATIVE AND QUANTITATIVE COMPOSITION
Each ml contains:
Active substance:
Ceftiofur (as hydrochloride) 50.0 mg
Excipients:
For a full list of excipients, see section 6.1
3. PHARMACEUTICAL FORM
Suspension for injection.
Slightly yellow to slightly pink, milky suspension.
4. CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cattle and pigs.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Infections associated with bacteria sensitive to ceftiofur:
In pigs:
For the treatment of bacterial respiratory disease associated with _Pasteurella multocida_, _Actinobacillus _
_pleuropneumoniae_ and _Streptococcus suis_.
In cattle:
For the treatment of bacterial respiratory disease associated with _Pasteurella haemolytica_ (_Mannheimia_ spp.),
_Pasteurella multocida_ and _Haemophilus somnus_.
For the treatment of acute interdigital necrobacillosis (panaritium, foot rot), associated with _Fusobacterium _
_necrophorum_ and _Bacteroides melaninogenicus_ (_Porphyromonas asaccharolytica_).
For treatment of the bacterial component of acute post-partum (puerperal) metritis within 10 days after calving
associated with _Escherichia coli_, _Arcanobacterium pyogenes_ and_ Fusobacterium necrophorum_, sensitive to
ceftiofur. The indication is restricted to cases where treatment with another antimicrobial has failed .
4.3 CONTRAINDICATIONS
Do not administer to an animal previously found to be hypersensitive to ceftiofur and other β -lactam antibiotics.
Do not use in case of known
Read the complete document
